Replies to post #3746 on Ayala Pharmaceuticals Inc (ADXS)

[DewDiligence]

ADXS hires head of clinical development:

http://finance.yahoo.com/news/advaxis-appoints-dr-shelonitda-rose-130500379.html

Advaxis, Inc...today announced that it has appointed Shelonitda S. Rose, M.D., as Vice President, Clinical Development. Dr. Rose brings to Advaxis more than 15 years of experience in medical oncology and hematology clinical research.

Most recently, Dr. Rose served as Director, Oncology Clinical Research for Merck & Co., Inc. She joined Merck in October 2010 and in her role was the medical monitor for multiple programs including KEYTRUDA, for which she was the clinical lead for Hodgkin Lymphoma studies. Dr. Rose also designed, authored and executed clinical studies, and developed the hematology strategy.